DVA
72
-3
MPC
47
3
PDCO
30
-6
ALLE
41
-7
EXR
59
4
HPE
70
2
EFX
41
-2
FTI
78
-3
NSC
64
2
DE
36
-2
DTE
38
-4
DLTR
40
4
TROW
51
-2
LEG
31
3
STX
52
-4
VZ
42
3
STI
31
19
FDX
54
14
KLAC
45
-4
KHC
17
4
DVA
72
-3
MPC
47
3
PDCO
30
-6
ALLE
41
-7
EXR
59
4
HPE
70
2
EFX
41
-2
FTI
78
-3
NSC
64
2
DE
36
-2
DTE
38
-4
DLTR
40
4
TROW
51
-2
LEG
31
3
STX
52
-4
VZ
42
3
STI
31
19
FDX
54
14
KLAC
45
-4
KHC
17
4
Financhill
Back

Dyne Therapeutics 10K Form

Buy
66

DYN
Dyne Therapeutics

Last Price:
30.84
Seasonality Move:
38.02%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive DYN News And Ratings

See the #1 stock for the next 7 days that we like better than DYN

DYN Financial Statistics

Sales & Book Value

Annual Sales: $4.84B
Cash Flow: $-55.73M
Price / Cash Flow: 0
Annual Sales: $7.74
Price / Book: 3.81

Profitability

EPS (TTM): -3.59000
Net Income (TTM): $-257.6M
Gross Margin: $1.91B
Return on Equity: 0%
Return on Assets: 0%

Dyne Therapeutics Earnings Forecast

Key Dyne Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 13 years for DYN is 39.45%.
  • The Selling, General & Administrative Expenses for DYN have been equal to 3.90% of Gross Profit Margin.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 19 years have been positive in 8 years.

Dyne Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: DYN
CUSIP: 26818M
Website: dyne-tx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

DYN Technical Analysis vs Fundamental Analysis

Buy
66
Dyne Therapeutics (DYN) is a Buy

Is Dyne Therapeutics a Buy or a Sell?

  • Dyne Therapeutics stock is rated a Buy
    The current Dyne Therapeutics [DYN] share price is $34.14. The Score for DYN is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.